LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

Search

ResMed Inc

Fechado

SetorSaúde

222.01 -2.09

Visão Geral

Variação de preço das ações

24h

Atual

Mín

220.91

Máximo

227.67

Indicadores-chave

By Trading Economics

Rendimento

44M

393M

Vendas

87M

1.4B

P/E

Médio do Setor

22.571

57.05

Rendimento de Dividendos

1

Margem de lucro

27.593

Funcionários

10,600

EBITDA

63M

566M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+30.88% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.00%

2.52%

Próximos Ganhos

22 de abr. de 2026

Próxima data de dividendos

11 de jun. de 2026

Próxima data de ex-dividendo

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-4B

33B

Abertura anterior

224.1

Fecho anterior

222.01

Sentimento de Notícias

By Acuity

10%

90%

11 / 349 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de mar. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26 de mar. de 2026, 23:36 UTC

Conversa de Mercado
Notícias Principais

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26 de mar. de 2026, 23:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Pernod Ricard: Confirms Discussions With Brown-Forman

26 de mar. de 2026, 23:29 UTC

Ganhos

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26 de mar. de 2026, 23:28 UTC

Ganhos

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26 de mar. de 2026, 23:28 UTC

Ganhos

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26 de mar. de 2026, 23:28 UTC

Ganhos

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26 de mar. de 2026, 23:27 UTC

Ganhos

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26 de mar. de 2026, 23:27 UTC

Ganhos

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26 de mar. de 2026, 23:08 UTC

Conversa de Mercado

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26 de mar. de 2026, 23:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26 de mar. de 2026, 23:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26 de mar. de 2026, 23:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26 de mar. de 2026, 23:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26 de mar. de 2026, 23:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Pernod in Deal Talks With Brown-Forman -- WSJ

26 de mar. de 2026, 22:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26 de mar. de 2026, 22:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26 de mar. de 2026, 22:26 UTC

Ganhos

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26 de mar. de 2026, 22:26 UTC

Ganhos

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26 de mar. de 2026, 22:26 UTC

Ganhos

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26 de mar. de 2026, 22:08 UTC

Ganhos

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26 de mar. de 2026, 22:08 UTC

Ganhos

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26 de mar. de 2026, 22:08 UTC

Ganhos

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26 de mar. de 2026, 22:07 UTC

Conversa de Mercado
Notícias Principais

Global Energy Roundup: Market Talk

26 de mar. de 2026, 22:07 UTC

Conversa de Mercado
Notícias Principais

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26 de mar. de 2026, 22:00 UTC

Ganhos

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26 de mar. de 2026, 22:00 UTC

Ganhos

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26 de mar. de 2026, 22:00 UTC

Ganhos

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26 de mar. de 2026, 21:39 UTC

Aquisições, Fusões, Aquisições de Empresas

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26 de mar. de 2026, 21:38 UTC

Aquisições, Fusões, Aquisições de Empresas

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

30.88% parte superior

Previsão para 12 meses

Média 296.2 USD  30.88%

Máximo 345 USD

Mínimo 265 USD

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

12 ratings

7

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

11 / 349 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat